Backed by a $26M US Federal contract to develop a Human body-on-a-chip and building on technologies developed at the Massachusetts Institute of Technology, CN Bio is one of the pre-eminent Organ-on-Chip firms in this emerging field.
Location: United Kingdom, England, South Hams
Phone: +44 1223 737941
Total raised: $30M
Investors 1
Date | Name | Website |
- | Oxford Uni... | innovation... |
Funding Rounds 2
Date | Series | Amount | Investors |
23.04.2024 | Series B | $21M | - |
02.03.2020 | - | $9M | - |
Mentions in press and media 20
Date | Title | Description | Source |
23.04.2024 | CN Bio's Series B Funding Boosts OOC Technology Expansion | CN Bio, a pioneer in microphysiological systems, secures $21 million in Series B funding to accelera... | parsers.vc... |
23.04.2024 | CN Bio Raises $21M in First Close of Series B Round | CN Bio, a Cambridge, UK-based provider of single- and multi-organ microphysiological systems, raised... | finsmes.co... |
23.04.2024 | CN Bio raises $21 million USD in first close of Series B inv... | Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, res... | cambridgen... |
27.02.2023 | CN Bio extends microphysiological system portfolio with Phys... | Cambridge, UK - CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single... | cambridgen... |
17.01.2023 | The FDA further expands collaboration with CN Bio to evaluat... | CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ... | cambridgen... |
05.10.2021 | CN Bio expands service offering to support oncology drug dis... | CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-orga... | cambridgen... |
05.10.2021 | CN Bio expands service offering to support oncology drug dis... | CN Bio expands service offering to support oncology drug discovery 05-10-2021 CN Bio, a leading Orga... | cambridgen... |
05.05.2021 | FDA expands collaboration with CN Bio to investigate lung-on... | CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that... | cambridgen... |
05.05.2021 | FDA expands collaboration with CN Bio to investigate lung-on... | FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluatio... | cambridgen... |
18.03.2021 | CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphys... | CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System 18-03-2021 CN Bio, a le... | cambridgen... |
Show more